Top 15 Life Science Angel Investors in Asia (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jan Hammer
Angel
|
2 | China, United States, France | Series A, Series B, Seed | Health Care, Medical, Medical Device | $2.5M–$231M |
|
Kuldeep Rajput
Angel
|
2 | Singapore | Pre-Seed, Series A | Life Science, Biotechnology | |
|
Wendou Niu
Angel
|
1 | Singapore | Series A | Life Science, Biotechnology | |
|
Raman Singh
Angel
|
1 | Singapore | Series A | Life Science, Biotechnology | |
|
Shirley Clayton
Angel
|
1 | Japan | Seed | Life Science, Biotechnology | |
|
Hiroaki Kitano
Angel
|
1 | Japan, United States | Seed, Angel | Medical, Health Care, Fitness | $2.7M–$7.1M |
|
Kenshin Fujiwara
Angel
|
1 | Japan | Seed, Series A | Mobile, Medical, Software | |
|
Hirofumi Miki
Angel
|
1 | Japan | Seed, Angel, Pre-Seed | Content, Artificial Intelligence, Internet | $252k–$2M |
|
Yuriko Minami
Angel
|
1 | Japan | Series A, Seed, Pre-Seed | Medical, Biotechnology, SNS | $3M–$4.7M |
|
Shoji Okamoto
Angel
|
1 | Japan | Seed | Lifestyle, Life Science, Service Industry | |
|
Gong Hongjia
Angel
|
1 | China | Angel, Seed, Series B | Biotechnology, Medical, Life Science | $1.4M–$14M |
|
Hidetoshi Takano
Angel
|
1 | Japan, United States | Seed, Angel | Internet, Information Technology, Content | $255k–$30M |
|
Shoji Miyata
Angel
|
1 | Japan | Seed, Series A | Mobile, Travel, Organic | $487k–$764k |
|
Kengo Suzuki
Angel
|
1 | Japan | Seed, Pre-Seed | EdTech, Education, Metaverse | $194k–$610k |
|
Shin Sugiyama
Angel
|
1 | Japan | Series A | Biometrics, Life Science, Biotechnology | |
| Access all 15 angel investors in Asia Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States, France
Investor stats
- Total investments: 143
- Round size: Seed $2.5M–$20M; Series A $3M–$35M; Series B $14M–$231M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
- Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Founder & CEO @ Biofourmis
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Pre-Seed, Series A
- Geography: Singapore
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Co-founder & Chief Privacy Officer @ Biofourmis
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Investment focus
- Industry: Life Science, Biotechnology
- Stage:Series A
- Geography: Singapore
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Prior to joining the board in February 2007, Ms. Clayton retired as President and Chief Executive Officer of Abmaxis, Inc., which was acquired by Merck & Co. As VP and Treasurer at Genentech, Inc., the first biopharmaceutical company, Ms. Clayton was actively involved in the early financing of the biotechnology industry. Prior to her role atAbmaxis, she co-founded Raven Biotechnologies, a cell biology company developing monoclonal antibody products, and served as its President and Chief Financial Officer. During her 25 years as an executive in the life science industry, Ms. Clayton was Chief Financial Officer, President or Chief Executive Officer in several companies including Protein Design Labs, now PDL BioPharma, Inc.; Cygnus, Inc., a drug delivery company; and CBYON, a medical technology company sold to GE Medical Systems. She is a member of the Board and Audit committee of Metro Bancorp and a member of the Board of Metro United Bank and Chairman of its Credit committee. Ms. Clayton received a BS in Chemistry from Smith College and an MBA from the Stanford University Graduate School of Business.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Modalis Therapeutics — Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
Senior Executive Vice President and CTO at Sony Group Corporation and President & CEO at Sony Computer Science Laboratories, Inc.. He attended Waseda University.
Show more...Investment focus
- Industry: Medical, Health Care, Fitness
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 8
- Round size: Seed $2.7M–$7.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GPx — GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts.
- AnotherBall — AnotherBall is a blockchain startup that combines entertainment and blockchain.
- SBX Corporation — AI R&D: Deep learning, Machine learning, Automation, Text mining. Development, customization and maintenance of software platforms for drug discovery and life science research.
Kenshin is a CEO at Hacarus Inc., a healthcare technology startup based in Kyoto, Japan.He co-founded several tech startups with 2 exits in the past 15 years. His first career started as an engineer at Sony Computer Entertainment and worked on PlayStation development projects. HIs fist startup was acquired by Japanese public company, and thesecond startup was sold to the US company.Born in 1976. He holds a Computer Science degree from California State University. He loves mountain hiking and currently living in Kyoto Japan with his wife and family.
Show more...Investment focus
- Industry: Mobile, Medical, Software
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Helpfeel — Our vision is to make saving, sharing, and exploring ideas as natural as breathing. On this journey we're humbled to be helping millions around the world from solo makers to university research labs, from gamers to pro designers, and large to small teams like ours.
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
After JTB Co., Ltd. and CYBIRD Co., Ltd. as an initial member of Glee Co., Ltd. is responsible for business development. Currently, he is mainly engaged in venture support in the Internet area, investing in venture and venture capital, and served as management advisor for dozens of companies. Hands-on business development, growth strategydevelopment, financing advice, HR organization design support, partner referral and Recruit Support. He is also engaged in business support for ventures in the healthcare and university venture fields. He served as Digital Health Meetup Advisor, NEDOTCP Mentor and Future 2016 Mentor.
Show more...Investment focus
- Industry: Content, Artificial Intelligence, Internet
- Stage:Seed, Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 27
- Round size: Seed $252k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Go Visions — Go Visions engages in the edutainment tech for children and human resources services.
- Ai-Dounyu.com — Ai-Dounyu.com is a platform that helps organizations looking to integrate AI choose their ideal AI implementation partner for free.
- Compass — Compass is a Solve problems in the local labor market with Consultation x Technology
Yuriko Minami is the Capitalist at Mirai Sozo Organization.
Show more...Investment focus
- Industry: Medical, Biotechnology, SNS
- Stage:Series A, Seed, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 6
- Round size: Series A $3M–$4.7M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- digzyme — Digzyme develops new enzymatic processes using bioinformatics. The company automates various stages of analysis related to the development of enzymes and bioprocesses using their core bioinformatics technology and further optimize using accumulated data.
- Varinos — Varinos is a clinical laboratory contract analysis company that is a partner of medical institutions. Varinos provides genomic testing development and contract analysis services using the latest technology, the next-generation sequencer.
- Metagen Therapeutics — Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access.
Shoji Okamoto is the President of Mirai Works.
Show more...Investment focus
- Industry: Lifestyle, Life Science, Service Industry
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Monoun — Mono.un provides users with opportunities to meet authors and collaborate on tales and specializes in bringing exciting experiences full of stories of Japanese culture to the world.
- Memory Lab — Memory Lab is a research laboratory that offers AI paper analysis and development solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Gong Hongjia is the the founder of Jiadao Capital.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Angel, Seed, Series B
- Geography: China
Investor stats
- Total investments: 11
- Round size: Angel $1.4M–$14M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
- Snow Origin — Snow Origin is a Beijing deep-tech company specializing in neural interfaces and surface EMG (sEMG) interaction. They build BCI peripheral hardware to deliver natural, stable human-computer interaction for next-generation AR/VR headsets and smart devices.
- CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.
Joined Intelligence in 1999. Established Key Players Inc. in 2005. Consultation with more than 3,000 managers and career counseling for more than 10,000 individuals. In addition, we have invested in more than 55 outside directors, advisors and angels in Silicon Valley and Bangladesh in Japan. Over 100 lectures on careers, entrepreneurship andstartups.
Show more...Investment focus
- Industry: Internet, Information Technology, Content
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 42
- Round size: Seed $255k–$7.1M; Angel $4.3M–$30M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Kaimak — Kaymak is a recruitment platform that focuses on creating a recruitment website, planning a recruitment strategy, and managing candidates.
- D-Chain — D-Chain offers services related to IT development and production in the Web3 and Web2 fields.
- Rayout — Rayout is a business consulting company that provides creative content development, recruitment videos, and web production services.
Shoji Miyata is the CEO of SmartHR.
Show more...Investment focus
- Industry: Mobile, Travel, Organic
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 5
- Round size: Seed $487k–$764k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Morus — Morus is a university-based biotech startup developing functional food ingredients from silkworms to address global health and nutrition challenges.
- Epicbase — Epicbase is an AI-based automatic voice transcription service based on voice recognition technology.
- Somewhere — Somewhere is engaged in the travel and transportation business.
Kengo Suzuki is the Co-Founder of Glocalink Singapore. Kengo attended The University of Tokyo.
Show more...Investment focus
- Industry: EdTech, Education, Metaverse
- Stage:Seed, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 4
- Round size: Seed $194k–$610k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MoonJapan — MoonJapan is an educational impact startup that offers a variety of programs and thorough assistance.
- Memory Lab — Memory Lab is a research laboratory that offers AI paper analysis and development solutions.
- ElevationSpace — ElevationSpace offers high quality & well equipped workspaces giving tenants a nurturing environment .
Shin Sugiyama is the Business Promotion Department at Fuji Nippon Sugar.
Show more...Investment focus
- Industry: Biometrics, Life Science, Biotechnology
- Stage:Series A
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- digzyme — Digzyme develops new enzymatic processes using bioinformatics. The company automates various stages of analysis related to the development of enzymes and bioprocesses using their core bioinformatics technology and further optimize using accumulated data.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!